Covid and Aortic Conditions: The Latest Research
54:00-55:01
Q:
Would you say that those with recurrent pneumothoracies, or spontaneous, spontaneous lung collapse, so people with recurrent pneumothoracies, are they at high risk regardless of their age and is there any data that has given any insight into how important recurrent pneumothoracies are on outcomes?
再発性気胸のある方では、年齢に関わらず重症化リスクが高くなるのでしょうか？再発性気胸がCOVIDの転帰に大きく関わることを示すデータはありますか？
A:
No, there's not specific data on patients who have kind of recurrent pneumothoracies, kind of, as a kind of a baseline comorbidity.
基礎疾患として再発性気胸をお持ちのCOVID患者さんについての具体的なデータはありません。
But what we do know is that in a subset of patients who develop COVID they actually develop pneumothoracies as a complication of having COVID because of the destructive effects of the pneumonia on the lung.
ですが、COVIDに感染した一部の患者さんでは、COVIDの合併症として気胸を起こしています。原因は肺炎による肺の損傷です。
And so the reason the rationale behind considering that kind of a high risk diagnosis is the kind of, the, the belief that that reflects kind of chronic damage to the lung and reduction of their overall kind of pulmonary reserve, which is what I see in most of my patients who have recurrent pneumothoracies.
再発性気胸で重症化リスクが高くなる根拠として、慢性的な肺の損傷により、肺の予備能が低下することが考えられます。こうした症例は、私が診た再発性気胸の患者さんの大部分で確認しています。
The Marfan Foundation did not participate in the translation of these materials and does not in any way endorse them. If you are interested in this topic, please refer to our website, Marfan.org, for materials approved by our Professional Advisory Board.
The Marfan Foundation は、当翻訳には関与しておらず、翻訳内容に関してはいかなる承認も行っておりません。このトピックに興味をお持ちの方は、Marfan.org にアクセスし、当協会の専門家から成る諮問委員会が承認した内容をご参照ください。
